awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33511437-5A4804C6-4A98-40BA-9161-900BAC72330D
Q33511437-5A4804C6-4A98-40BA-9161-900BAC72330D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33511437-5A4804C6-4A98-40BA-9161-900BAC72330D
Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10).
P2860
Q33511437-5A4804C6-4A98-40BA-9161-900BAC72330D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33511437-5A4804C6-4A98-40BA-9161-900BAC72330D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
263076d984a302550daf4c5a318b1a26cdba0904
P2860
Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.